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Where Are We Now?

P

rosthetic joint infection (PJI)
prevention in arthroplasty has
focused on patient selection,
medical optimization, and the selection
and administration of parenteral antibiotics. Other approaches to avoid PJI
are seeing more-common use, including antibiotic loaded bone cement
(ALBC) [9], vancomycin powder [7],
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or other beaded delivery mechanisms
[6]. However, these approaches have
come under scrutiny because of concerns like antibiotic resistance and
toxicity following prolonged exposures [1].
In their current study, Young and
colleagues propose using intraosseous
regional administration (IORA) to increase antibiotic levels at the site of
surgery. Their proposed method of
delivery would provide lower doses in
a more rapid fashion to decrease the
risk of toxicity while still seeking to
maintain adequate tissue perfusion.
The authors look at maximizing the
local concentration of antibiotics while
limiting exposure, toxicity, and duration of use after surgery. They also
evaluate the use of this technique in
revision knee arthroplasty, which is
important because further prospective
clinical studies will likely be carried
out in this population, given their increased risk for postoperative infections. Bringing IORA into the clinical
setting will be a challenge since the
technique is one that many of us soon
forgot after our days of Advance
Trauma Life Support training. Local
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administration of antibiotics through
a foot vein has been explored, but
getting to the vein would require
adjustments to draping since access to
the foot intraoperatively after the elevation of the tourniquet would be
necessary [4].
For years, the value of ALBC has
been debated. Do the purported beneﬁts
justify the signiﬁcant cost increases?
Perhaps the utilization of IORA can
provide the regional administration of
antibiotics without the inﬂated cost of
ALBC [2, 3, 9]. Techniques like IORA
provide an alternative that may meet the
challenges of both groups, while also
providing the clinical beneﬁts to the
patients in need of adequate prophylaxis.

Where Do We Need To Go?
Minimizing the risk of infection after
primary and revision arthroplasty is
important given the increasing demand
for arthroplasty surgery [8]. However,
we must also be mindful about how we
use antibiotics given the risks of antibiotic resistance and the increase in
more-resistant organisms as primary
pathogens in PJI [1]. Parenteral antibiotics have been a mainstay of practice
since the 1970s; to cause a major shift
from this to IORA, more-compelling
evidence will be needed. Although we
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have seen recommendations to discontinue the use of prophylactic antibiotics once the surgical incision is
closed regardless of drain presence [1],
a switch to IORA is more likely to occur
now due to the increased calls for improved antibiotic management and
postoperative administration practices
[5]. Future studies will need to provide
evidence of comparable tissue concentrations after surgery, decreased systemic toxicity, and the ease of
administration before using IORA in
the clinical setting. There are also
complication concerns, speciﬁcally improper administration of ﬂuid causing
extravasation, which could lead to
compartment syndrome. Other complications such as fracture, hematoma, or
pain are less signiﬁcant, but are likely to
occur more frequently.

How Do We Get There?
Although the current study was robust,
replication of research is important; we
ﬁrst need to ensure that the ﬁndings
generalize well to other settings by
repeating this study in other centers.
Next, researchers should evaluate
IORA in patients with renal insufﬁciency and evaluate the safety in

these patient populations. Because infection is so uncommon after primary
TKA, enormous studies would be
needed, and this seems impractical; it
seems to me that evaluating IORA in
revision TKA patients is a morepromising approach, given that their
risk of infection after surgery is so
much greater. A comparison of IORA
versus ALBC, vancomycin powder,
and antibiotic bead delivery mechanisms would be of interest to many
surgeons.
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